Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
APR | Ann:Fund update | 27/03/19 | 0 | 24 | |||
|
|||||||
APR | Ann:Fund Update - Debt Facility and Liquidity Event (Price Sensitive) | 25/03/19 | 0 | 43 | |||
|
|||||||
APR | Ann:March quarter 2019 distribution | 19/03/19 | 0 | 4.7K | |||
|
|||||||
APR | Ann:Withdrawal Offer Letter & Withdrawal Request Form (Price Sensitive) | 04/02/19 | 0 | 362 | |||
|
|||||||
APR | Ann:Appendix 2C + Half Year report for 31 Dec 2018 (Price Sensitive) | 04/02/19 | 0 | 248 | |||
|
|||||||
APR | Ann:Investor Presentation (Price Sensitive) | 04/02/19 | 0 | 430 | |||
|
|||||||
APR | Ann:PDS, Application Form & Entitlement Form (Price Sensitive) | 04/02/19 | 0 | 369 | |||
|
|||||||
APR | Ann:Fund update, capital raising & Liquidity Event launch (Price Sensitive) | 04/02/19 | 0 | 381 | |||
|
See All Discussions